Raymond James Starts Nektar Therapeutics (NKTR) at Market Perform
Tweet Send to a Friend
(Updated - October 8, 2026 4:07 PM EDT)
Raymond James analyst Thomas Deal initiates coverage on Nektar Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Thomas Deal initiates coverage on Nektar Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




